Racial differences and the genetics of hypertension

被引:20
作者
Cooper R.S. [1 ]
Zhu X. [1 ]
机构
[1] Department of Preventive Medicine and Epidemiology, Loyola University Stritch, School of Medicine, Maywood, IL 60153
关键词
Blood Pressure Regulation; Hypertension Risk; Etiologic Research; Liddle Syndrome; Family Blood Pressure Program;
D O I
10.1007/s11906-001-0073-z
中图分类号
学科分类号
摘要
Variation in the prevalence of hypertension among human populations has been used to examine a wide range of research questions. The best known example has always been the twofold greater prevalence among blacks, which has provoked a debate about the relative importance of environmental and genetic factors. This problem is complicated because it requires an understanding of both the genetics of hypertension and the genetic basis of variation among populations. Molecular data accumulated over the past year are beginning to provide new insights into this old question. Modest progress has now been made in the genetics of hypertension. Important advances have been made in understanding rare hypertension syndromes, and large-scale studies of the general population are under way, although the results to date are inconclusive. Markers used to search for hypertension genes can also provide estimates of between-population variability. These data, which are based on genetic variants used for etiologic research, confirm previous evidence of group-specific variation, while underscoring the limited magnitude of this variation. Despite rapid progress, this work is still in its infancy and raises more questions than it answers. Copyright © 2001 by Current Science Inc.
引用
收藏
页码:19 / 24
页数:5
相关论文
共 29 条
[1]  
Cooper R.S., Rotimi C., Hypertension in populations of West African origin. Is there a genetic predisposition?, Am J Hypertens, 12, pp. 215-227, (1994)
[2]  
Geller D.S., Farhi A., Pinkerton N., Et al., Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy, Science, 289, pp. 119-123, (2000)
[3]  
Warnock D.G., Liddle syndrome: An autosomal dominant form of human hypertension, Kidney Int, 53, pp. 18-24, (1998)
[4]  
Lifton R.P., Molecular genetics of blood pressure regulation, Science, 272, pp. 676-680, (1996)
[5]  
Agerholm-Larsen B., Nordestgaard B.H., Tyhjaerg-Hansen A., ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites, Arterioscler Thromb Vasc Biol, 2, pp. 484-492, (2000)
[6]  
Zhu X., McKenzie C., Forrester T., Et al., Localization of a small genomic region associated with elevated ACE, Am J Hum Genetics, 67, pp. 1144-1153, (2000)
[7]  
Keavney B., McKenzie C., Parish S., Et al., Large-scale test of hypothesized associations between the angiotensinconverting enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators, Lancet, 355, pp. 434-442, (2000)
[8]  
Rotimi C., Cooper R., Ogunbiyi O., Et al., Hypertension, serum angiotensinogen and molecular variants of the angiotensinogen gene among Nigerians, Circulation, 95, pp. 2348-2350, (1997)
[9]  
Province M.A., Boerwinkle E., Chakravarti A., Et al., Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program, J Hypertens, 18, pp. 867-875, (2000)
[10]  
Williams S.M., Addy J.H., Phillips J.A., Et al., Combinations of variations in multiple genes are associated with hypertension, Hypertension, 36, pp. 2-6, (2000)